ReMonit Gout
Mastering app for uric acid
Project Manager
PhD fellow
Postdoc
ABOUT THE PROJECT
O gout is an inflammatory rheumatic disease characterized by recurrent, highly painful seizures. If you go with an elevated uric acid level in the blood over time, uric acid crystals are formed, which can lead to an acute inflammatory reaction in the joints.
O gout is the only of the inflammatory rheumatic diseases that can be cured, ie patients can avoid having seizures if they get properly dosed drug treatment and if they continue to take the drugs daily.
In today's course of treatment, all patients who start uric acidic drugs receive a conversation with a nurse, who informs about the disease, the treatment target, drug treatment and dietary advice. The patient is then followed up with monthly blood sampling and telephone consultation with a nurse until the treatment target is reached.
In the Remonit Gout study, we will investigate whether the Urika app can support patients during uric acid treatment. Appen er utviklet i samarbeid med brukerrepresentanter og spesialister og er grundig testet av 21 pasienter i en anvendbarhetsstudie.
The app contains information films and text about the disease and treatment methods, reminders for medication and blood tests, and a graph with an overview of the uric acid level. It also has a function for adapting medicine doses and a nurse messaging service.
A nurse will provide digital distance follow -up via a digital platform related to the app. We will test the digital follow-up in a clinical study (randomized, controlled, non-inferiority study) to investigate whether the follow-up is no worse than today's telephone follow-up with a nurse.
WHO CAN JOIN?
Participants in the study will be recruited among adult patients referred to the Diakonhjemmet Hospital, who are diagnosed with gout germination and will start with uric acid treatment.
Participants cannot have any other serious illnesses, poor kidney or liver function, or being pregnant or breastfeeding.
It is also a requirement that the participants own a smartphone or tablet and have good Norwegian knowledge.
WHAT DOES THE STUDY INCLUDE?
The study lasts for 2 years. All patients receive a first consultation with a nurse at Diakonhjemmet Hospital. Patients who agree to participate in the study are randomly distributed (by drawing) to one of two groups:
- A group (the control group) should be followed up according to today's treatment course with monthly telephone consultations with a nurse.
- The other group (intervention group) will receive follow -up using the Self -Mastery app Urika and is followed up digitally by a nurse.
All participants should take blood tests and respond to a digital questionnaire at start -up, and after 1 and 2 years.
In addition, everyone will be asked to answer a few short questions every 3 months.
Blood tests are taken each month until the treatment target is reached, then three months after the goal is reached.
Everyone who participates in the study will be summoned to a consultation with a nurse in the hospital after 1 year.
Then the patients will be followed up by their GP with blood tests approx. Every 6 months.
After 2 years, participants will again be called to a consultation with a nurse, which is carried out at the hospital or by phone.
After 1 and 2 years, we will evaluate if digital follow-up is not inferior a nurse-led follow-up with telephone consultations. We will also do a health economic evaluation of the two follow -up strategies.